Harrow Stock Financials

HROW -  USA Stock  

USD 9.69  0.14  1.47%

Understanding current and past Harrow Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Harrow Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Harrow Health's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Harrow Health's financials over time to get the whole picture.
Harrow Health Average Assets are fairly stable at the moment as compared to the past year. Harrow Health reported Average Assets of 53.32 Million in 2020. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is likely to climb to about 1.8 M in 2021, whereas Average Equity is likely to drop slightly above 16.6 M in 2021.
Please harness Harrow Health fundamental data analysis to find out if markets are presently mispricing the company. We were able to break down and interpolate data for thirty-six available reported financial drivers for Harrow Health, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Harrow Health financials, including its debt to equity, and the relationship between the gross profit and price to earnings to growth . Given that Harrow Health has a number of shares shorted of 1.86 M, we strongly advise you to confirm Harrow Health regular market performance to make sure the company can sustain itself down the road. Use Harrow Health to enhance returns of your portfolios. The stock experiences a large bullish trend. Check odds of Harrow Health to be traded at $10.66 in 90 days.

Harrow Fundamentals 

With this module, you can analyze Harrow financials for your investing period. You should be able to track the changes in Harrow Health individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
The fundamental analysis of Harrow Health is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Harrow Health includes many different criteria found on its balance sheet. For example, investors should never minimize Harrow Health's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Harrow Health's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Harrow Health.

Harrow Health Cash

  Chance Of Financial Distress
Less than 29
Harrow Health has less than 29 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Harrow Health stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Harrow Health's official financial statements usually reflect Harrow Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Harrow Health. For example, before you start analyzing numbers published by Harrow accountants, it's critical to develop an understanding of what Harrow Health's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Harrow Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Harrow Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Harrow Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Harrow Health. Please utilize our Beneish M Score to check the likelihood of Harrow Health's management to manipulate its earnings.

Harrow Health Company Summary

Harrow Health competes with Glg Life, and Mind Medicine. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 125 people.
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
LocationTennessee; U.S.A
Business Address102 Woodmont Boulevard
IndustryDrug Manufacturers—Specialty & Generic
Phone615 733 4730
Related EntityHROW
CurrencyUSD - US Dollar
You should never invest in Harrow Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Harrow Stock, because this is throwing your money away. Analyzing the key information contained in Harrow Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Harrow Health Key Financial Ratios

Generally speaking, Harrow Health's financial ratios allow both analysts and investors to convert raw data from Harrow Health's financial statements into concise, actionable information that can be used to evaluate the performance of Harrow Health over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Harrow Health reports annually and quarterly.

Harrow Health Key Balance Sheet Accounts

201620172018201920202021 (projected)
Total Assets27.25 M23.92 M49.45 M59.09 M57.47 M62.01 M
Current Assets14.75 M8.81 M32.84 M36.05 M40.13 M43.3 M
Assets Non Current12.49 M15.11 M16.61 M23.04 M17.34 M14.57 M
Cash and Equivalents9.05 M4.22 M6.84 M4.95 M4.3 M5.76 M
Total Debt13.69 M15.33 M15.25 M20.99 M23.53 M18.8 M
Debt Current4.43 M598 K3.25 M2.41 M4.49 M3.57 M
Debt Non Current9.26 M14.73 M12 M18.58 M19.05 M16.03 M
Deferred Revenue91 K29 K119 K57 K66 K73.91 K
Shareholders Equity6.43 M2.62 M24.75 M27.71 M27.18 M29.33 M
Inventory1.84 M2.25 M1.83 M3.3 M3.96 M3.32 M
Total Liabilities20.82 M21.3 M24.7 M31.67 M30.65 M33.07 M
Current Liabilities9.9 M5.77 M11.9 M12.28 M10.8 M8.9 M

Harrow Health Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Harrow Health's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201620172018201920202021 (projected)
Consolidated Income(19.09 M)(11.98 M)14.62 M(125 K)(3.42 M)(3.69 M)
Cost of Revenue9.83 M13.51 M16.52 M16.75 M14.46 M14.01 M
Gross Profit10.11 M13.27 M24.85 M34.42 M34.41 M37.12 M
Interest Expense2.77 M3.03 M2.73 M2.5 M2.24 M2.02 M
Net Income(19.09 M)(11.98 M)14.62 M168 K(3.36 M)(3.62 M)
Operating Expenses25.99 M25.43 M30.07 M39.21 M34.02 M28.44 M
Operating Income(15.88 M)(12.16 M)(5.22 M)(4.79 M)385 K415.39 K
Revenues19.94 M26.77 M41.37 M51.16 M48.87 M52.73 M

Harrow Health Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Harrow Health. It measures of how well Harrow is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Harrow Health brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Harrow had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Harrow Health has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201620172018201920202021 (projected)
Capital Expenditure(6.89 M)(772 K)(1.77 M)(1.47 M)(862 K)(930.05 K)
Depreciation Amortization and Accretion1.41 M1.76 M1.84 M2.66 M2.74 M2.96 M
Net Cash Flow or Change in Cash and Cash Equivalents6.17 M(4.83 M)2.62 M(1.89 M)(648 K)(665.05 K)
Issuance Purchase of Equity Shares20.52 M4.24 M4.88 M769 K(29 K)(29.76 K)
Issuance Repayment of Debt Securities2.5 M893 K(691 K)(1.77 M)1.46 M1.32 M
Net Cash Flow from Financing24.67 M4.93 M4.13 M(1.01 M)1.43 M1.47 M
Net Cash Flow from Investing(7.29 M)(961 K)(2.2 M)(1.83 M)(981 K)(1.06 M)
Net Cash Flow from Operations(11.21 M)(8.8 M)687 K950 K(1.1 M)(1.19 M)
Share Based Compensation3.67 M2.94 M2.49 M1.79 M2.77 M2.82 M

Harrow Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Harrow Health's current stock value. Our valuation model uses many indicators to compare Harrow Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Harrow Health competition to find correlations between indicators driving Harrow Health's intrinsic value. More Info.
Harrow Health is one of the top stocks in number of shares shorted category among related companies. It is one of the top stocks in market capitalization category among related companies creating about  138.63  of Market Capitalization per Number of Shares Shorted. Harrow Health Market Capitalization is fairly stable at the moment as compared to the past year. Harrow Health reported Market Capitalization of 176.62 Million in 2020. Comparative valuation analysis is a catch-all model that can be used if you cannot value Harrow Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Harrow Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Harrow Health's earnings, one of the primary drivers of an investment's value.

Harrow Health Systematic Risk

Harrow Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Harrow Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Harrow Health correlated with the market. If Beta is less than 0 Harrow Health generally moves in the opposite direction as compared to the market. If Harrow Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Harrow Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Harrow Health is generally in the same direction as the market. If Beta > 1 Harrow Health moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Harrow Health Financials

What exactly are Harrow Health Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Harrow Health's income statement, its balance sheet, and the statement of cash flows. Potential Harrow Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Harrow Health investors may use each financial statement separately, they are all related. The changes in Harrow Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Harrow Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
 2018 2019 2020 2021 (projected)
Current Assets32.84 M36.05 M40.13 M43.3 M
Total Assets49.45 M59.09 M57.47 M62.01 M
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Harrow Health is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Harrow grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Harrow Health October 28, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Harrow Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Harrow Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Harrow Health based on widely used predictive technical indicators. In general, we focus on analyzing Harrow Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Harrow Health's daily price indicators and compare them against related drivers.
Downside Deviation2.78
Information Ratio0.0724
Maximum Drawdown16.89
Value At Risk(3.98)
Potential Upside5.99
Please check Risk vs Return Analysis. Note that the Harrow Health information on this page should be used as a complementary analysis to other Harrow Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Harrow Stock analysis

When running Harrow Health price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Harrow Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.